focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Feb 2010 07:00

RNS Number : 5796H
Chamberlin PLC
24 February 2010
 



24 February 2010

Chamberlin plc

("Chamberlin" or "the Company")

 

Director / PDMR Shareholding

 

 

The Company has today announced that the Board has approved the grant of options to the Executive Directors under the Chamberlin Share Option Plan (the "SOP"). At the same time the Directors will surrender all of their existing share options granted under the SOP, The Chamberlin & Hill Approved Share Plan (the "Approved Plan") and the Chamberlin & Hill Unapproved Share Plan (the "Unapproved Plan"). Tim Hair will also surrender some of his existing share options granted under The Chamberlin Performance Share Plan (the "PSP").

 

The Directors have been granted the following options:

 

Director

Number of options surrendered

Number of options retained under PSP*

Number of parallel options awarded under SOP*

Number of new options awarded under SOP

Total number of options

Tim Hair

Mark Bache

Adam Vicary

576,987

250,971

51,000

193,935

152,367

99,222

193,935

152,367

99,222

698,584

293,892

49,531

892,519

446,259

148,753

 

* The options retained under the PSP will be subject to the existing performance criteria as defined by the scheme. In the event that these options fail to vest, those SOP options awarded in parallel to the PSP scheme will become exercisable, subject to the performance conditions below. In the event that the PSP options are exercised the equivalent number of SOP options will be cancelled.

 

Excluding the parallel grant of SOP options, which is on an either/or basis with existing PSP options, in total 878,958 options are being surrendered and 1,042,007 new options issued. It remains the Company's intention to restrict the actual dilution of existing ordinary share capital to no more than 10% through the use of market purchased shares or cash in lieu of the exercise of options, in so far as this is prudently possible.

 

The SOP options are exercisable at a price of 52.8 pence each, based on the average closing mid-market price over the past 30 trading days, at any time between 23 February 2013 and 23 February 2020. They will vest subject to a TSR performance equivalent to achieving minimum share price of 100 pence on a theoretical no dividends basis (at which one third of the options will vest) up to a maximum price equivalent to 180p on the same basis at which all SOP options will vest, with vesting calculated on a straight line basis between these points. Performance will be tested over a period of three years from 23 February 2010.

 

The options surrendered by Tim Hair, Mark Bache and Adam Vicary were cancelled on 23 February 2010.

 

For further information:

 

Chamberlin plc T: 01922 707100

Tom Brown, Chairman

Tim Hair, Chief Executive

 

Charles Stanley Securities T: 020 7149 6000

Nominated Adviser

Russell Cook/Jen Boorer

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTJMLTMBMTBLM
Date   Source Headline
10th Mar 202110:38 amRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting
21st Jan 20217:00 amRNSTrading Statement
4th Jan 20217:30 amRNSSuspension - Chamberlin Plc
18th Dec 20205:43 pmRNSPublication of Audited Accounts
16th Dec 202011:55 amRNSTrading Update
27th Nov 20207:00 amRNSPublication of Audited Accounts
24th Nov 20207:15 amEQSHardman & Co Research: Chamberlin (CMH): Trading update ‒ main businesses performing solidly
23rd Nov 20207:00 amRNSTrading Update
6th Nov 20207:00 amRNSPublication of Audited Accounts
29th Sep 202010:42 amEQSHardman & Co Research: Chamberlin (CMH): Trading update most encouraging
29th Sep 20207:00 amRNSPublication of 2020 Accounts and Trading Update
23rd Jul 20205:48 pmRNSHolding(s) in Company
19th Jun 202012:15 pmRNSTrading Update
30th Mar 202012:45 pmEQSHardman & Co Research: Chamberlin Plc (CMH): Trading stalled in these unprecedented times
27th Mar 20202:24 pmRNSTrading Update
18th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSHolding(s) in Company
17th Feb 202011:52 amEQSHardman & Co Research: Chamberlin Plc (CMH): Near-term trading subdued
13th Feb 20205:53 pmRNSTrading Statement
6th Dec 20197:01 amRNSContract award for Walsall foundry
6th Dec 20197:00 amRNSContract award for Scunthorpe foundry
22nd Nov 20197:00 amRNSHolding(s) in Company
19th Nov 201911:55 amEQSHardman & Co Research: Chamberlin Plc (CMH): Management actions yield cautious optimism
18th Nov 20197:00 amRNSHalf-year Report
4th Nov 20197:00 amRNSNotice of Interim Results
21st Oct 20191:01 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSHolding(s) in Company
23rd Jul 20194:05 pmRNSResult of AGM
23rd Jul 20197:00 amRNSBoard Retirement
23rd Jul 20197:00 amRNSAGM Statement
19th Jun 201910:14 amRNSHolding(s) in Company
4th Jun 20197:31 amEQSHardman & Co Research: Chamberlin (CMH): Trading remains difficult; forecasts lowered
4th Jun 20197:00 amRNSFinal Results
30th May 201912:35 pmRNSTrading Update
21st Feb 20192:23 pmRNSHolding(s) in Company
6th Feb 20192:06 pmEQSHardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered
5th Feb 20197:52 amRNSTrading Update
24th Dec 20187:00 amRNSHalf-year Report
20th Dec 20187:00 amRNSSale of Exidor Limited
12th Dec 20187:00 amRNSChange of Adviser
12th Nov 20187:00 amRNSAppointment of Finance Director
2nd Aug 20187:00 amRNSDirectorate Change
24th Jul 20182:57 pmRNSResult of AGM
24th Jul 20187:00 amRNSAGM Statement
19th Jun 20183:39 pmRNSGrant of Options
5th Jun 201811:45 amEQSHardman & Co Research: Chamberlin pLC (CMH): Trading strong, technical issues largely resolved
5th Jun 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.